The body’s own mechanism for dispersing the inflammatory reaction might lead to new treatments for chronic pain.

WINDSOR, Ont. — A wave of new prescription painkillers presents a potential danger to society, some medical researchers warn.

Told he had only months to live and given 14 times the painkillers his previous doctor prescribed, Charles Groomes died years later

ProStrakan, Inc., a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that the U.S. Food and Drug Administration has approved the TIRF (Transmucosal Immediate Release Fentanyl) REMS Access program.

Shortly after a car struck 66-year-old Juan Pablo Hernandez Rodriguez in a Fairfax City crosswalk Dec. 23, he was talking, stood up and initially didn’t want to be taken to a hospital, police said. When Rodriguez did go to Inova Fairfax Hospital , scans showed that he had no broken bones. Doctors gave him pain medication and crutches to ease his sore knee, elbow and back, and then they sent him …

THURSDAY, Dec. 29 (HealthDay News) –Overcrowding in emergency rooms appears to keep children with broken arms and legs from getting pain relief in a timely manner, according to a new study.

Some opioid painkillers used by cancer patients are governed by U.S. Food and Drug Administration plans to manage possible health risks. The FDA is changing how it manages these drugs and these changes should help Raleigh, North Carolina company BioDelivery Sciences International (NASDAQ:BDSI). Here’s how. BDSI’s product Onsolis delivers the painkiller fentanyl through a small piece […]

A red-tailed hawk that became an avian sensation when a webcam followed her nesting and rearing a chick on a high-rise ledge died after surgery to amputate her badly injured foot, a wildlife rehabilitation group said.

BEDMINSTER, N.J. , Dec. 30, 2011 /PRNewswire/ – ProStrakan, Inc., a subsidiary of Kyowa Hakko Kirin Co. Ltd. (KHK), and an international specialty pharmaceutical company, today announces that the U.S. …

The U.S. Food and Drug Administration today approved a single shared Risk Evaluation and Mitigation Strategy (REMS) for the transmucosal immediate-release fentanyl (TIRF) products. This new shared system will replace the individual REMS and allow prescribers and pharmacies to enroll into just one system, easing the burden on the health care system.